chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing
Clinical narrative: flushing on chest; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of FLUSHING (flushing on chest) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced FLUSHING (flushing on chest). On 05-Jan-2021, FLUSHING (flushing on chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Gastroesophageal reflux and Osteopenia.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 07-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included muscle relaxant, medicine for reflux and osteopenia.   This case was linked to MOD-2021-019461 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rash
Clinical narrative: Rash (Back); Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash (Back)) and MYALGIA (Body Aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced RASH (Rash (Back)) and MYALGIA (Body Aches). At the time of the report, RASH (Rash (Back)) and MYALGIA (Body Aches) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm, Vaccination site pruritus
Clinical narrative: Sore arm; Delayed reaction where her arm was hot; Arm  was swollen; Arm  was red; itched like crazy/circumference of a softball around the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), SKIN WARM (Delayed reaction where her arm was hot), PERIPHERAL SWELLING (Arm  was swollen), ERYTHEMA (Arm  was red) and VACCINATION SITE PRURITUS (itched like crazy/circumference of a softball around the site of the injection) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), SKIN WARM (Delayed reaction where her arm was hot), PERIPHERAL SWELLING (Arm  was swollen), ERYTHEMA (Arm  was red) and VACCINATION SITE PRURITUS (itched like crazy/circumference of a softball around the site of the injection). On 24-Jan-2021, PAIN IN EXTREMITY (Sore arm), SKIN WARM (Delayed reaction where her arm was hot), PERIPHERAL SWELLING (Arm  was swollen), ERYTHEMA (Arm  was red) and VACCINATION SITE PRURITUS (itched like crazy/circumference of a softball around the site of the injection) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided. The patient received cortisone cream to help with the itching.   This case was linked to MOD-2021-177969 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26-May-2021 and updated that consumer does not want further calls or follow-up from Moderna. No other new information reported or that pertains to the first dose.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: fatigue; chills; Fever of 105F; severe pain in the arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (severe pain in the arm), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (Fever of 105F) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (severe pain in the arm). On 22-Jan-2021, the patient experienced FATIGUE (fatigue), CHILLS (chills) and PYREXIA (Fever of 105F). At the time of the report, PAIN IN EXTREMITY (severe pain in the arm), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (Fever of 105F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 105 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Illness, Pain, SARS-CoV-2 test
Clinical narrative: didn't feel well; Headache; Body ache; Got a Covid-19 test and received a positive Covid-19 diagnosis; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got a Covid-19 test and received a positive Covid-19 diagnosis), ILLNESS (didn't feel well), HEADACHE (Headache) and PAIN (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (Got a Covid-19 test and received a positive Covid-19 diagnosis). On an unknown date, the patient experienced ILLNESS (didn't feel well), HEADACHE (Headache) and PAIN (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COVID-19 (Got a Covid-19 test and received a positive Covid-19 diagnosis), ILLNESS (didn't feel well), HEADACHE (Headache) and PAIN (Body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Very limited information regarding this event has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Tension, Vaccination site discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE PARAESTHESIA (she was also tingling), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense) and VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 27L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis (About 20 years ago) and Autoimmune disorder.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PARAESTHESIA (she was also tingling). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense), VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) and VACCINATION SITE ERYTHEMA (Red mark the size of a nickel/big red mark). At the time of the report, VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE PARAESTHESIA (she was also tingling), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense) and VACCINATION SITE ERYTHEMA (Red mark the size of a nickel/big red mark) outcome was unknown and VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Medical history and event information was updated.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE PARAESTHESIA (she was also tingling), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense) and VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 27L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis (About 20 years ago) and Autoimmune disorder.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PARAESTHESIA (she was also tingling). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense), VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) and VACCINATION SITE ERYTHEMA (Red mark the size of a nickel/big red mark). At the time of the report, VACCINATION SITE PRURITUS (Arm got itchy/it is itchy), VACCINATION SITE PARAESTHESIA (she was also tingling), VACCINATION SITE DISCOMFORT (Felt like there was something under her arm), TENSION (Tense) and VACCINATION SITE ERYTHEMA (Red mark the size of a nickel/big red mark) outcome was unknown and VACCINATION SITE PAIN (Whole arm was very sore/still painfull under the arm, ackey) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Medical history and event information was updated.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Arm was hot; Large area of redness; Arm was a little tender; A spontaneous report was received from a consumer concerning a  male patient of unknown age, received Moderna's COVID-19 vaccine (mRNA-1273 and experienced large area of redness/ erythema, arm was a little tender/ tenderness and hot feeling hot  The patient's medical history was not reported. No irrelevant concomitant medication were reported   On 9 feb 2021, the patient received their first dose of mRNA-1273 (Lot number: 029K20A) intramuscularly in left  arm  for prophylaxis of COVID-19 infection. On 9 feb 2021, prior to receiving mRNA-1273 the patient experienced erythema, tenderness and feeling hot . The patient did not receive any treatment  Action taken with mRNA-1273 in response to the event was unknown  Outcome of the events,  large area of redness/ erythema, arm was a little tender/ tenderness and hot /feeling hot were unknown
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Swollen arm; it had a big red spot; it was itchy; A spontaneous report was received from an other healthcare concerning a 71 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swollen arm/peripheral swelling, it had a big red spot/rash macular, it was itchy/pruritus.   The patient's medical history included chronic lymphocytic leukemia. Products known to have been used by the patient, within two weeks prior to the event, included fluoxetine hydrochloride and centromine.    The patient received their first of two planned doses of mRNA-1273 (Batch number: 013C20A) on 19 Jan 2021 in the left arm for prophylaxis of COVID-19 infection.   Ten days after receiving the vaccine patient experienced swollen arm, it had a big red spot, it was itchy. Treatment for the event included Paracetamol and Ibuprofen.   Action taken with mRNA-1273 in response to the event(s) was not provided.  The events swollen arm, it had a big red spot and it was itchy was resolved on unknown date.
Sex: U
Vaccine: COVID19
Symptoms: Injection site mass
Clinical narrative: Patient had an immediate large bump/mound; A spontaneous report was received from a consumer concerning a patient of un unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced an event of injection site bump.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the event the patient received their first of two planned doses of mRNA-1273 (Batch Number: 037K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Jan 2021, the patient experienced the event of an immediate large bump/mound (injection site bump).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event injection site bump was considered resolved on 28 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: skin rash; Severe hive rash around waist; A spontaneous report  was received from a consumer concerning a 85-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events skin rash/ Rash, Severe hive rash around waist/ Urticaria.  The patient do not have any medical history. Concomitant medications  were not reported.  On 13/Jan/2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 026L20A) intramuscularly for prophylaxis of COVID-19 infection.  On  20/Jan/2021, the patient experienced the events Severe hive rash around waist. Nurse stated that about a week later patient had severe hive rash around her waist and saw a family doctor and was put on a dose pack.  Case for patient #1- Crosslinked to other 5 AEs reported Dose pack treatment  was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s) skin rash/ Rash, Severe hive rash around waist/ Urticaria was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm sored but now it's gone; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm sored but now it's gone) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Arm sored but now it's gone). At the time of the report, INJECTION SITE PAIN (Arm sored but now it's gone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Fatigue, Nausea
Clinical narrative: burning in stomach; nausea; light fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (burning in stomach), NAUSEA (nausea) and FATIGUE (light fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced NAUSEA (nausea) and FATIGUE (light fatigue). On 20-Jan-2021, the patient experienced DYSPEPSIA (burning in stomach). The patient was treated with OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) at an unspecified dose and frequency and FAMOTIDINE at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (burning in stomach), NAUSEA (nausea) and FATIGUE (light fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided    Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: This follow up contains no new information.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Injection site cellulitis
Clinical narrative: This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PEAU D'ORANGE (Cellulite on the injection site) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for an unknown indication.     The patient's past medical history included No adverse event (No medical history reported).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PEAU D'ORANGE (Cellulite on the injection site). At the time of the report, PEAU D'ORANGE (Cellulite on the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included antibiotics as prescribed by HCP
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Lower respiratory tract congestion, Myalgia
Clinical narrative: tender; ring around the injection site the size of an orange; red patches on arms and legs; developed welts; injection arm was red; Chest congestion; cough; stuffy; sinus symptoms in her head; full blown severe chills; headache; body aches; fever between 100-101F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Historical Condition.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), CHILLS (full blown severe chills), HEADACHE (headache) and PYREXIA (fever between 100-101F). On 27-Jan-2021, the patient experienced LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough). On 28-Jan-2021, the patient experienced RASH (red patches on arms and legs), URTICARIA (developed welts) and VACCINATION SITE ERYTHEMA (injection arm was red). On an unknown date, the patient experienced VACCINATION SITE REACTION (ring around the injection site the size of an orange) and TENDERNESS (tender). At the time of the report, PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion), COUGH (cough), RASH (red patches on arms and legs), URTICARIA (developed welts), VACCINATION SITE REACTION (ring around the injection site the size of an orange), TENDERNESS (tender), CHILLS (full blown severe chills), HEADACHE (headache), PYREXIA (fever between 100-101F) and VACCINATION SITE ERYTHEMA (injection arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, Rash, Sinus headache, Vaccination site erythema
Clinical narrative: tender; ring around the injection site the size of an orange; red patches on arms and legs; developed welts; injection arm was red; Chest congestion; cough; stuffy; sinus symptoms in her head; full blown severe chills; headache; body aches; fever between 100-101F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Historical Condition.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), CHILLS (full blown severe chills), HEADACHE (headache) and PYREXIA (fever between 100-101F). On 27-Jan-2021, the patient experienced LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough). On 28-Jan-2021, the patient experienced RASH (red patches on arms and legs), URTICARIA (developed welts) and VACCINATION SITE ERYTHEMA (injection arm was red). On an unknown date, the patient experienced VACCINATION SITE REACTION (ring around the injection site the size of an orange) and TENDERNESS (tender). At the time of the report, PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion), COUGH (cough), RASH (red patches on arms and legs), URTICARIA (developed welts), VACCINATION SITE REACTION (ring around the injection site the size of an orange), TENDERNESS (tender), CHILLS (full blown severe chills), HEADACHE (headache), PYREXIA (fever between 100-101F) and VACCINATION SITE ERYTHEMA (injection arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site reaction, Vaccination site urticaria
Clinical narrative: tender; ring around the injection site the size of an orange; red patches on arms and legs; developed welts; injection arm was red; Chest congestion; cough; stuffy; sinus symptoms in her head; full blown severe chills; headache; body aches; fever between 100-101F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Historical Condition.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), CHILLS (full blown severe chills), HEADACHE (headache) and PYREXIA (fever between 100-101F). On 27-Jan-2021, the patient experienced LOWER RESPIRATORY TRACT CONGESTION (Chest congestion) and COUGH (cough). On 28-Jan-2021, the patient experienced RASH (red patches on arms and legs), URTICARIA (developed welts) and VACCINATION SITE ERYTHEMA (injection arm was red). On an unknown date, the patient experienced VACCINATION SITE REACTION (ring around the injection site the size of an orange) and TENDERNESS (tender). At the time of the report, PAIN (body aches), NASAL CONGESTION (stuffy), SINUS HEADACHE (sinus symptoms in her head), LOWER RESPIRATORY TRACT CONGESTION (Chest congestion), COUGH (cough), RASH (red patches on arms and legs), URTICARIA (developed welts), VACCINATION SITE REACTION (ring around the injection site the size of an orange), TENDERNESS (tender), CHILLS (full blown severe chills), HEADACHE (headache), PYREXIA (fever between 100-101F) and VACCINATION SITE ERYTHEMA (injection arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a physician (subsequently medically confirmed), describes the occurrence of vaccination site pain (arm soreness - near injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 immunization. No medical history reported. On Jan 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Jan 28, 2021, patient experienced vaccination site pain (arm soreness - near injection site). At the time of the report, vaccination site pain (arm soreness - near injection site) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, treatment information or concomitant medications
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID infection; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID infection) in a 121-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for an unknown indication.     No Medical History information was reported.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (COVID infection). At the time of the report, COVID-19 (COVID infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Influenza like illness, Myalgia, Vaccination site pain
Clinical narrative: Flu like symptoms; PAIN IN ARM; Joint pain; Body pain; CHILLS; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (PAIN IN ARM), ARTHRALGIA (Joint pain), MYALGIA (Body pain) and CHILLS (CHILLS) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No reported medical history).    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (PAIN IN ARM), ARTHRALGIA (Joint pain), MYALGIA (Body pain) and CHILLS (CHILLS). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (PAIN IN ARM), ARTHRALGIA (Joint pain), MYALGIA (Body pain) and CHILLS (CHILLS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: arm became super red; hard; hot; itchy; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (arm became super red), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot) and VACCINATION SITE PRURITUS (itchy) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for an unknown indication.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm became super red), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE ERYTHEMA (arm became super red), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter..
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: headache; arm soreness; muscle ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), VACCINATION SITE PAIN (arm soreness), MYALGIA (muscle ache) and FATIGUE (fatigue) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy (undergoing Chemotherapy once a month.) since an unknown date. Concurrent medical conditions included Multiple myeloma. Concomitant products included OXYCODONE for Back pain, AMLODIPINE BESILATE (AMLODIPINE BESYLATE 10) and LABETALOL HCL for Hypertension, MORPHINE HCL for Pain, FOLIC ACID for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced HEADACHE (headache), VACCINATION SITE PAIN (arm soreness), MYALGIA (muscle ache) and FATIGUE (fatigue). At the time of the report, HEADACHE (headache), VACCINATION SITE PAIN (arm soreness), MYALGIA (muscle ache) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included Potassium Hydrochloride as Supplements and Ranncol-Rite 100 mg for stool softener(constipation). No treatment medications were provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Fever; Redness at the injection site; Red knot at the injection site; Itchy at the injection site; Warm to the touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE INDURATION (Red knot at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE WARMTH (Warm to the touch at the injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE INDURATION (Red knot at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE WARMTH (Warm to the touch at the injection site). At the time of the report, PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved and VACCINATION SITE INDURATION (Red knot at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE WARMTH (Warm to the touch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blister infected, Paraesthesia, Pruritus, Vaccination site swelling
Clinical narrative: pinpricky; blister on finger; itchiness on her hands and feet; swelling of left arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pinpricky), BLISTER INFECTED (blister on finger), PRURITUS (itchiness on her hands and feet) and VACCINATION SITE SWELLING (swelling of left arm at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PARAESTHESIA (pinpricky), BLISTER INFECTED (blister on finger), PRURITUS (itchiness on her hands and feet) and VACCINATION SITE SWELLING (swelling of left arm at injection site). At the time of the report, PARAESTHESIA (pinpricky), BLISTER INFECTED (blister on finger), PRURITUS (itchiness on her hands and feet) and VACCINATION SITE SWELLING (swelling of left arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The  concomitant medications on use were not provided. No laboratory data was provided. Treatment included cortisone cream.   This case was linked.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Cough, Injection site pruritus, Malaise, Pain in extremity
Clinical narrative: not doing well; redness like rash; itching; swelling; burning; horrible cough; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not doing well), PAIN IN EXTREMITY (arm pain), RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching) and SWELLING (swelling) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid cancer and Thyroidectomy. Concomitant products included GABAPENTIN, CALCIUM and LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Jan-2021, the patient experienced COUGH (horrible cough). On 21-Jan-2021, the patient experienced RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching), SWELLING (swelling) and BURNING SENSATION (burning). On 27-Jan-2021, the patient experienced MALAISE (not doing well). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN (ADVIL COLD, COUGH & FLU NIGHTTIME) for Cough, at a dose of 200 mg. At the time of the report, MALAISE (not doing well), PAIN IN EXTREMITY (arm pain), RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching), SWELLING (swelling), BURNING SENSATION (burning) and COUGH (horrible cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient informed that she has a rare nerve condition, complex regional pain syndrome which she got 24 years ago after her thyroid cancer surgery.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI, follow-up declined by the patient.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Swelling
Clinical narrative: not doing well; redness like rash; itching; swelling; burning; horrible cough; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not doing well), PAIN IN EXTREMITY (arm pain), RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching) and SWELLING (swelling) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid cancer and Thyroidectomy. Concomitant products included GABAPENTIN, CALCIUM and LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Jan-2021, the patient experienced COUGH (horrible cough). On 21-Jan-2021, the patient experienced RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching), SWELLING (swelling) and BURNING SENSATION (burning). On 27-Jan-2021, the patient experienced MALAISE (not doing well). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN (ADVIL COLD, COUGH & FLU NIGHTTIME) for Cough, at a dose of 200 mg. At the time of the report, MALAISE (not doing well), PAIN IN EXTREMITY (arm pain), RASH ERYTHEMATOUS (redness like rash), INJECTION SITE PRURITUS (itching), SWELLING (swelling), BURNING SENSATION (burning) and COUGH (horrible cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient informed that she has a rare nerve condition, complex regional pain syndrome which she got 24 years ago after her thyroid cancer surgery.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI, follow-up declined by the patient.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Vaccination site discomfort
Clinical narrative: having trouble with shoulder - left arm; having trouble being able to lift arm - left arm; left arm hurts - can't even lift it over my head; never gotten a shot so close to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (having trouble with shoulder - left arm), PAIN IN EXTREMITY (having trouble being able to lift arm - left arm), PAIN IN EXTREMITY (left arm hurts - can't even lift it over my head) and VACCINATION SITE DISCOMFORT (never gotten a shot so close to shoulder) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced ARTHRALGIA (having trouble with shoulder - left arm), PAIN IN EXTREMITY (having trouble being able to lift arm - left arm), PAIN IN EXTREMITY (left arm hurts - can't even lift it over my head) and VACCINATION SITE DISCOMFORT (never gotten a shot so close to shoulder). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (having trouble with shoulder - left arm), PAIN IN EXTREMITY (having trouble being able to lift arm - left arm), PAIN IN EXTREMITY (left arm hurts - can't even lift it over my head) and VACCINATION SITE DISCOMFORT (never gotten a shot so close to shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient takes Blood pressure and Cholesterol Medications
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: arm soreness; substantial headache; A spontaneous report was received from a consumer concerning a unspecified age   of female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm soreness and substantial headache . The patient's medical history was not provided by the reporter. Concomitant medications  were not provided by the reporter. On 20 Feb 2021  prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273  via intra muscular  in unknown anatomical location  for prophylaxis of COVID-19 infection.  After receiving the first dose ,the patient experienced arm soreness and substantial headache . Action taken with mRNA-1273 in response to the events was  unknown. The events of outcome of the events  arm soreness and substantial headache was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Swelling, Vaccination complication, Vaccination site induration
Clinical narrative: Adverse events; Circle around injection site; Redness; Swelling (L); Hard around injection site; Fatigue; Pain at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness), SWELLING (Swelling (L)), VACCINATION SITE REACTION (Circle around injection site), VACCINATION COMPLICATION (Adverse events) and VACCINATION SITE INDURATION (Hard around injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included VITAMINS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site). On 23-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard around injection site). On 25-Jan-2021, the patient experienced ERYTHEMA (Redness) and SWELLING (Swelling (L)). On 28-Jan-2021, the patient experienced VACCINATION SITE REACTION (Circle around injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse events). On 24-Jan-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. On 25-Jan-2021, VACCINATION SITE INDURATION (Hard around injection site) and FATIGUE (Fatigue) had resolved. On 28-Jan-2021, ERYTHEMA (Redness) and SWELLING (Swelling (L)) had resolved. On 01-Feb-2021, VACCINATION SITE REACTION (Circle around injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Adverse events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included acetaminophen, diphenhydramine and ice.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site reaction
Clinical narrative: Adverse events; Circle around injection site; Redness; Swelling (L); Hard around injection site; Fatigue; Pain at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness), SWELLING (Swelling (L)), VACCINATION SITE REACTION (Circle around injection site), VACCINATION COMPLICATION (Adverse events) and VACCINATION SITE INDURATION (Hard around injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included VITAMINS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site). On 23-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard around injection site). On 25-Jan-2021, the patient experienced ERYTHEMA (Redness) and SWELLING (Swelling (L)). On 28-Jan-2021, the patient experienced VACCINATION SITE REACTION (Circle around injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse events). On 24-Jan-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. On 25-Jan-2021, VACCINATION SITE INDURATION (Hard around injection site) and FATIGUE (Fatigue) had resolved. On 28-Jan-2021, ERYTHEMA (Redness) and SWELLING (Swelling (L)) had resolved. On 01-Feb-2021, VACCINATION SITE REACTION (Circle around injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Adverse events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included acetaminophen, diphenhydramine and ice.